Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Oxytocin for Post-Hysterectomy Pain
NCT05608070Phase 4Withdrawn
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Modality
- Peptides
01
Overview
A Phase 4 trial of oxytocin in postoperative pain, sponsored by Beth Israel Deaconess Medical Center. Planned start Jun 2023; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05608070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05608070.